Clinical Flashcards
embryonic stage of lung development
3rd to 7th week
at 28 days R and L mainstem bronchi are present
44th day PA from 6th aortic arch
initial branching into 5 lobes
failure to complete separation from esophagus
TE fistula
pseudoglandular stage
glandular appearance
weeks 5-17
rapid branching of pulmonary tree
mucus glands develop by 14th week
canalicular stage
16th to 24th week
capillary bed expands and endothelium thins
becomes thin enough to allow gas exchange
acceleration of tissue thinning and surfactant production
glucocorticoids
failure of capillary beds to form
alveolar capillary dysplasia
saccular stage
decrease in mesenchymal tissue
increase in type II maturation and surfactant
factor that decreases surfactant production
maternal diabetes
alveolar stage
36 weeks to 2-3 years
increased epithelial cells (most are type 2 pneumocytes but type 1 covers most of the alveolar structure)
changes in pulmonary vasculature
failure to change pulmonary vasculature
PPHN
VEGF
promotes angiogenesis
when blocked increase in alveolar size similar to emphysema
involved in development of BPD and ROP
retinoic acid
increase alveolarization
may decrease BPD
estrogen and testosterone
estrogen required fr adequate levels of surfactant
testosterone slows lung development
surfactant components
dipalmitoylphosphatidylcholine
phospholipids
proteins
cholesterol
surfactant protein A
most abundant
recycled by type II pneumocyte
opsonin-important in phagocytosis
deficiency still compatible with life
surfactant protein B
small but fusogenic-enhances spread and stability of surfactant mono layer
required for extra-uterine life
surfactant protein C
most hydrophobic
must be activated by surfactant protein B
functions to recruit phospholipids to lipid layer
AD deficiency-develop interstitial pneumonitis/emphysema
surfactant protein D
largest surfactant protein
not involved in stabilizing or recycling surfactant
found in other organs
main function in innate immunity (e. coli, salmonella, pseudomonas, RSV, adeno, flu A)
increases secretion of surfactant
glucocorticoids
estrogen
thyroid hormone
decreased secretion of surfactant
insulin
sources of surfactant inactivation
aspiration-BM, formula, sterile water
meconium
swallowed blood
pneumonia
betamethasone
increases surfactant production
decreases division and bronchial length
worsens body and lung growth if given to the mother
improves lung maturation if given to fetus
signs of respiratory distress
tachypnea grunting nasal flaring retractions cyanosis
transient tachypnea of newborn
failure for lung fluid to be reabsorbed
hormonal changes from labor cause reversal of Na channels